Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive examination. Proponents often stress the potential for significant therapeutic outcomes, principally in diseases where conventional therapies have proven ineffective. However, crucially important to consider the significant financial investment associated with